I still very much dislike their switch to NPBT. It's irrelevant...why not stick with EBIT, EBITDA or NPAT... what is this NPBT just because the number looks higher we all know basic accounting metrics
"LaserBond has maintained its FY25 guidance, projecting revenue between $43.0-46.0m and NPBT between $4.1-4.7m"
- Forums
- ASX - By Stock
- Ann: US Expansion Plans Temporarily On Hold
LBL
laserbond limited
Add to My Watchlist
0.00%
!
36.0¢

I still very much dislike their switch to NPBT. It's...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.35M |
Open | High | Low | Value | Volume |
36.0¢ | 36.5¢ | 36.0¢ | $219.3K | 608.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49047 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 18685 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49047 | 0.360 |
5 | 79787 | 0.355 |
2 | 10132 | 0.350 |
2 | 30030 | 0.345 |
6 | 21741 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 14354 | 1 |
0.370 | 11746 | 2 |
0.380 | 75000 | 2 |
0.385 | 60000 | 2 |
0.390 | 43000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LBL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online